European Grant (Horizon 2020) awarded to SurgaColl

SurgaColl technologies has been awarded a European Grant (Horizon 2020) as part of a consortium of organisations working towards ‘Controlling Cartilage to Bone Transitions for improved Treatment of Bone defects and Osteoarthritis’. The consortium  is led by Erasmus University in Rotterdam and includes IRCCS in Genoa, Trinity College Dublin, Klinikum der Universität zu Köln, Royal Veterinary College, […]

the MedTech Strategist

We are excited to be involved at the forthcoming MedTech Strategist Innovation Summit in Dublin 25-27 April at the Shelbourne Hotel, Dublin, Ireland. We are delighted and privileged to have a presentation slot on Day 1 and would welcome you to come and listen to our CEO, Bill Allan. For more information, please click here […]

No bones about it, Surgacoll plans to create 25 jobs by 2019

Surgacoll, which has created a bone regeneration product from technology developed at the Royal College of Surgeons in Ireland (RCSI), has received the CE mark, certifying it for sale throughout the EU and plans to create 25 new jobs in the next three years. Surgacoll Technologies, a high potential start-up (HPSU) supported by Enterprise Ireland, intends […]

Technology Showcase in Westport, Ireland

SurgaColl were invited to present their exciting ChondroColl technology at the Technology Showcase event organised as part of the Mayo Arthroscopy Conference in Westport on Friday evening 24th February. The Mayo Arthroplasty Conference is the largest joint replacement conference on the island of Ireland. The conference is an annual event and is now in its […]

Medtech and Money event

Our CEO Bill Allan and Dr John Gleeson, CTO were excited to attend the 3rd Annual Conference Medtech and Money on 7-8 February in London. Bill presented to an audience of almost 550 delegates on day 2. The 3rd Annual Conference continued a relentless focus on quality peer-2-peer discussion, high level networking and partnering, unique […]

New Website

SurgaColl are proud to announce the launch of their new website. It’s bright and energised look and feel are a true reflection of the great work that is happening within our company today.

New CEO for SurgaColl

We are delighted to announce the appointment of a new CEO to the SurgaColl business. Bill (William) Allan is an internationally experienced medical devices executive who has held a number of general management and leadership positions with global medical device companies, including Smith & Nephew, Angiodynamics, Orthovita and Stryker. He has a strong track record of […]

New publication – repair of osteochondritis dissecans lesions

SurgaColl  are pleased to have a new publication to add to their extensive library of evidence. Entitled ‘Repair of large osteochondritis dissecans lesions using a novel multilayered tissue engineered construct in an equine athlete’, it makes extremely interesting reading. Click here to read the publication

New paper by Dr Tanya Levingstone

Following the the Publication of Dr Tanya Levingstone’s Paper this month on the repair of large osteochondritis dissecans lesions in a horse, ChondroColl has been reported on by a number of national and international news sites. For more information please click on the links below. RTE News Silicon Replubic Horsetalk.co.nz

New publication in Journal of Tissue Engineering and Regenerative Medicine

A fantastic new clinical case study has been published for SurgaColl entitled “Repair of large osteochondritis dissecans lesions using a novel multilayered tissue engineered construct in an equine athlete”. Here is the abstract: Osteochondral lesions resulting from osteochondritis dissecans are problematic to treat and present a significant challenge for clinicians. The aims of this study […]